About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Wednesday, July 12th, 2017

The QualityStocks
Daily Stock List


U.S. Stem Cell, Inc. (USRM)

InvestorsHub, MarketWatch, TradingView, and Money Morning reported on U.S. Stem Cell, Inc. (USRM), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

U.S. Stem Cell, Inc. is a developing company in the regenerative medicine/cellular therapy industry. It is a developer of novel autologous cell therapies, and a provider of physician based stem cell therapies to human and animal patients. The Company has three operating divisions: US Stem Cell Training, Vetbiologics, and US Stem Cell Clinic. The Company’s concentration is on the discovery, development, and commercialization of cell based therapeutics that prevent, treat or cure disease through repairing and replacing damaged or aged tissue, cells and organs and restoring their normal function.

The Company previously went by the name Bioheart, Inc. It changed its corporate name to U.S. Stem Cell, Inc. in October 2015. Established in 1999, U.S. Stem Cell is headquartered in Sunrise, Florida.

The Company’s business includes the development of proprietary cell therapy products and revenue generating physician and patient based regenerative medicine/cell therapy training services, cell collection and cell storage services, the sale of cell collection and treatment kits for humans and animals, and the operation of a cell therapy clinic.

Its lead product candidate is MyoCell®. This is a muscle stem cell therapy intended to improve cardiac function months or even years after a patient has suffered severe heart damage because of a heart attack.

In addition, MyoCell SDF-1 has received approval from the Food and Drug Administration (FDA) to begin human clinical trials. The intention of MyoCell SDF-1 is to be an improvement to MyoCell. Pertaining to its AdipoCell product, U.S. Stem Cell has applied to the FDA to start trials utilizing adipose derived stem cells or AdipoCell™ in patients with chronic ischemic cardiomyopathy.

In late March 2017, U.S. Stem Cell announced that it developed a strategic alliance with Advanced Stem Cell Rx (ASC), a U.S. based provider of regenerative medicine programs, including the development of autologous stem cell treatment centers across the U.S.  ASC is commercializing many of the proprietary treatments developed by U.S. Stem Cell. ASC is presently implementing turnkey programs into qualified practices throughout the U.S. ASC has contracted with practices in more than 20 U.S. states.

Last month, U.S. Stem Cell announced an aggressive plan to expand an additional 12 stem cell treatment centers and clinics in the U.S. The Company has been in discussions with the FDA concerning Regenerative Medicine Advanced Therapy (RMAT) Designation for the MyoCell product and at this time, it has decided not to further invest in RMAT Designation and instead invest and concentrate on its in-clinic therapies for patients.

In addition, in June, Mr. Steve Nudelberg, Principal Thinker of On the Ball Ventures, announced the partnership between Mr. John Salley (Entrepreneur, NBA Star, Actor, Philanthropist, and Vegan,) and Stem Cell Centers of Excellence. On June 24, 2017, Mr. Salley had his first stem cell procedure to harvest his own stem cells and create relief in his shoulders and knees.

Mr. Salley has suffered years of agonizing pain after a lucrative career in the National Basketball Association (NBA). He was set to have surgery on his knees and shoulders. However, in keeping with his vegan, clean philosophy, he partnered with Stem Cell Centers of Excellence to advocate for using one’s own body's stem cells to heal itself.

U.S. Stem Cell, Inc. (USRM), closed Wednesday's trading session at $0.0453, up 27.79%, on 8,671,075 volume with 494 trades. The average volume for the last 60 days is 6,805,846 and the stock's 52-week low/high is $0.0016/$0.1793.

Vitality Biopharma, Inc. (VBIO)

SmallCap Network, Stock Beast, and Promotion Stock Secrets reported earlier on Vitality Biopharma, Inc. (VBIO), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Vitality Biopharma, Inc.’s dedication is to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders. Since 2012, the Company has developed an innovative capability to produce molecules by way of glycosylation, a form of enzymatic biosynthesis that was originally developed to improve the taste of stevia, a high-potency sweetener. The platform is well suited for the discovery of new pharmaceutical products. Vitality Biopharma has its headquarters in Los Angeles, California.

Late in 2015, the Company successfully modified cannabidiol (CBD), which is not psychoactive, and in continuing work has created a novel class of pharmaceuticals called cannabosides. Cannabosides, upon ingestion, can enable the selective delivery of THC and cannabidiol (CBD) to the gastrointestinal tract. Site-specific delivery could enable oral drug formulations of cannabinoids to provide therapeutic benefits. This is while reducing or avoiding the systemic delivery of THC into the bloodstream.

Vitality can biosynthesize cannabinoid glycosides (cannabosides) via enzyme biosynthesis. The Company is one of only a very few groups worldwide who know how to produce and work with the enzymes that perform glycosylation. It has been centered on it because the same enzymes are used to modify the taste of the abovementioned stevia (steviol glycosides).

In early March 2017, Vitality Biopharma announced that it created a library of proprietary glycosides of THC (delta-9-tetrahydrocannabinol), the primary psychoactive chemical found in cannabis or marijuana that enable targeted delivery, which decreases or eliminates psychoactivity when used in oral drug formulations. The compounds are undergoing development as pharmaceuticals, which enable site-specific targeting of the THC in different tissues of the body, where it can exert therapeutic effects for the treatment of pain and inflammation.

Vitality Biopharma obtained DEA approval in December of 2016 for its research and development (R&D) facilities in California. It completed preclinical pharmacokinetics studies with its proprietary THC glycosides to analyze their bioavailability. The Company has confirmed that large concentrations can be delivered orally without significant transit of THC to the brain, enabling their formulation within pharmaceuticals where drug psychoactivity will be decreased or eliminated.

Vitality Biopharma announced in late March of this year that it has positive results indicating a new use for its proprietary prodrug cannabinoid delivery platform. Numerous colon cancer cell kinds were screened, each with unique combinations of genetic mutations that drive cancerous growth, and including a cell line known to express drug-resistance genes such as PD-L1.

Vitality Biopharma found that cannabidiol (CBD) universally inhibited cell growth at concentrations similar to established chemotherapeutics. In addition, the Company found that its cannabidiol prodrug was not toxic to the human cells at the concentrations tested, demonstrating the relative safety of its prodrug delivery system.

Recently, the Company announced that it obtained positive results demonstrating antimicrobial activity of cannabinoids. It filed for patent protection on the use of cannabinoid compounds for the treatment of microbes. This includes Clostridium difficile and other "superbug" pathogens.

Vitality Biopharma, Inc. (VBIO), closed Wednesday's trading session at $1.94, down 1.52%, on 210,516 volume with 301 trades. The average volume for the last 60 days is 153,096 and the stock's 52-week low/high is $0.48/$4.24.

Kush Bottles, Inc. (KSHB)

The Street, StreetAuthority Daily, Promotion Stock Secrets, CFN Media Group, Stock News Now, and SmallCapVoice reported previously on Kush Bottles, Inc. (KSHB), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Kush Bottles, Inc. is a premier supplier of packaging, accessories, and branding solutions for the legal cannabis industry. The Company provides certified child-resistant and custom-branded solutions in all states that permit medical or recreational cannabis use. The Company is the only marijuana packaging company with numerous full-service facilities across the United States. Kush Bottles has its corporate headquarters and California fulfillment center in Santa Ana, California, soon to be relocated to Garden Grove, California.

In addition, Kush Bottles has opened a new Product Development and Genomics Lab to produce unique terpene formulations. The lab is in San Diego, California, a globally renowned biotechnology hub.

The Company provides pop top bottles; child resistant exit, paper exit, and foil barrier bags; tubes; and polystyrene, polypropylene, or silicone containers to urban farmers, greenhouse growers, and medical and recreational cannabis dispensaries. It centers on providing the highest quality medical and food grade packaging.

Additionally, Kush’s emphasis is on choosing products that are environmentally friendly and manufactured within the U.S. Kush Bottles has an in-house marketing and branding team to serve clients. Kush’s team can help a business get their brand off the ground through creating logos, brochures, websites, and custom packaging.

The Company has launched the marijuana industry's first online system. The system allows customers to design custom-branded packaging solutions. The tool makes it easier for customers to place orders. The expectation is that this will lead to a higher conversion rate and a better Return on Investment (ROI).

Kush Bottles has launched its "Kush N Slide" child resistant exit bag. This is an addition to its growing product line of high quality, compliant packaging solutions. The Kush N Slide is certified child resistant per Title 16 CFR 1700. The design of it is to meet the strict packaging regulations that are in place in Colorado and Oregon.

In May of this year, Kush Bottles announced it acquired CMP Wellness, LLC (Los Angeles, California). CMP is a privately held distributor of vaporizers, cartridges, as well as accessories. CMP Wellness has been in the business of selling standard and customized vaporizer products since 2013.

Regarding CMP, financial highlights for the six-month period ended February 28, 2017 include CMP Revenue of $4.5 million, versus $1.2 million in the same period in 2016. CMP Net Income was $0.7 million, versus $0.3 million in the same period in 2016.

Furthermore, in May, Kush Bottles announced it acquired the web domain Roll-uh-Bowl.com. This is an online distribution platform for retail sales of collapsible and unbreakable medical-grade silicone water pipes. Roll-uh-Bowl.com sees an average of 39,500 web users’ monthly.

Kush Bottles, Inc. (KSHB), closed Wednesday's trading session at $2.20, down 0.45%, on 208,808 volume with 289 trades. The average volume for the last 60 days is 81,488 and the stock's 52-week low/high is $1.24/$5.00.

MassRoots, Inc. (MSRT)

The Street, Promotion Stock Secrets, SmallCapVoice, OTCtipReporter, Penny Stock 101, PennyStockLocks.com, PennyStockScholar, Profitable Trader Authority, Stock Commander, StockRockandRoll, SeeThruEquity Research, Damn Good Penny Picks, Penny Picks, CFN Media Group, Wealth Daily, Cannabis Financial Network News, Equities.com, Money Moring, Stock News Now, and OTCJournal reported earlier on MassRoots, Inc. (MSRT), and we also report on the Company, here at the QualityStocks Daily Newsletter.

MassRoots, Inc. is a foremost technology platform for medical cannabis patients and businesses. Individuals use its application to share their cannabis experiences and stay connected with local dispensaries. MassRoots has affiliations with the top organizations in the cannabis industry. These include the ArcView Group and the National Cannabis Industry Association. MassRoots is based in Denver, Colorado and the Company’s shares trade on the OTC Markets’ OTCQB.

MassRoots’ plan is to expand to manifold states. Businesses can use the Company to advertise their goods and services to cannabis consumers. MassRoots starts adding in features, including order ahead, delivery, and the in-app purchase of ancillary products as regulations allow. Cannabis enthusiasts collectively engage more than 300,000 times per day on the Company’s network.

MassRoots’ product pipeline includes Dispensary Finder & Menus; Product Pages & Reviews; Sponsored Posts 2.0; and Enhanced Profiles. Most of its advertising revenue has come from dispensaries and cannabis-brands in the states of California and Colorado.

The Company has some estimated 300-plus dispensaries actively posting on its network. These include the nation's foremost dispensaries: Native Roots, MiNDFUL, The Clinic, BuddyBoyBrands, Green Solution, Good Chemistry, Denver Relief, Natural Remedies, and Harborside Health Center.

This past January, MassRoots completed its acquisition of DDDigtal, d.b.a. "Whaxy". This is an online order-ahead and menu management platform. In June, MassRoots and HIGH TIMES announced that MassRoots made a strategic investment in High Times Holding Corporation, "High Times", the leading voice of the Cannabis Industry, in February 2017. HIGH TIMES is the world's leading cannabis media, events, and information business. As disclosed in MassRoots' Quarterly Report on Form 10-Q filed on May 22, 2017, MassRoots made the strategic equity investment in High Times Holdings Corporation.

This month, MassRoots announced that it and Odava, Inc. executed a Definitive Agreement for MassRoots to acquire Odava for cash and shares of MassRoots' common stock. Odava is an industry-leading platform technology, which provides compliance, point-of-sale (POS), and supply chain management for the cannabis industry. The closing of the acquisition is subject to certain closing conditions as detailed in MassRoots' Current Report on Form 8-K. MassRoots’ primary emphasis is expanding market share in states where Odava is able to report to state regulators through Franwell, Inc.'s METRC system, at present Oregon, Alaska, and Colorado.

MassRoots chief engineering priority is integrating its community of more than a million cannabis consumers with Odava. This will enable consumers to view pricing and inventory data in real-time, identifying the best strains and products via community-driven reviews, and galvanizing dispensaries to implement customer loyalty and deal programs to increase retention.

MassRoots, Inc. (MSRT), closed Wednesday's trading session at $0.6064, up 3.66%, on 661,518 volume with 524 trades. The average volume for the last 60 days is 547,606 and the stock's 52-week low/high is $0.38/$1.18.

General Cannabis Corp. (CANN)

StockOodles, Wealth Insider Alert, Market Intelligence Center Alert, StreetAuthority Daily, Promotion Stock Secrets, Marketbeat, TopPennyStockMovers, Wall Street Mover, Stockgoodies, PennyPro, Cannabis Financial Network News, Money Morning, SmallCapVoice, OTC Markets Group, and The Street reported on General Cannabis Corp. (CANN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

General Cannabis Corp. is a service provider to businesses in the regulated cannabis industry. Its mission is to lead the regulated cannabis industry through being a trusted partner to the cultivation, production, as well as retail side of the cannabis business. A synergistic holding company, it previously went by the name Advanced Cannabis Solutions, Inc. It changed its name to General Cannabis Corp. in June 2015. OTCQB-listed, General Cannabis has its corporate office in Denver, Colorado.

The Company leases grow and related facilities - commercial real estate and equipment - to licensed business operators for their production needs. Also, it is pursuing supplementary business products and services. These include customized finance, capital formation, banking, regulatory compliance consulting, security and advanced logistical support for grow operations.

General Cannabis has strong operating divisions. These include real estate, consulting, security, and financing. In addition, the Company distributes essential infrastructure products to grow facilities and dispensaries.

General Cannabis’ consulting division is Next Big Crop. This division provides practical experience and proven techniques for every phase of the cultivation, processing, and sale of cannabis. Services comprise business planning and application writing, to operations optimizations, management, and expansion.

Chiefton Supply Co. is a wholly-owned subsidiary of General Cannabis. Chiefton Supply is a causal lifestyle brand. Chiefton Supply provides an alternative to the classic marijuana T-shirt. It creates street wear apparel and accessories for men and women. Additionally, Chiefton Design delivers high quality brand development and design to the legal cannabis market.

Furthermore, Iron Protection Group (IPG) is a wholly-owned subsidiary of General Cannabis. IPG provides security and training services to government agencies, multinational corporations, diplomats, dignitaries, and non-profit organizations, domestically and internationally. Combat veterans of the wars in Iraq and Afghanistan manage and operate Iron Protection Group. IPG covers all things related to protection. This is from training individuals in the art of manipulating a firearm, to providing a personal security detail for any of a client’s security needs.

This past March, General Cannabis, in response to increasing demand, announced that its security division, Iron Protection Group (IPG), will start offering its services in California. By opening an office in Sacramento, IPG will serve the largest regulated cannabis market globally, now that California voted to legalize the recreational use of marijuana for adults in November 2016.

Mr. Glenn Weatherly, IPG Director of Operations, will lead the Company's California office. IPG is staffed mainly with United States military veterans. It expects to continue this practice in California.

Last month, General Cannabis announced the acquisition of GC Finance Arizona, LLC from Infinity Capital West, LLC.  GC Arizona owns two primary assets. One is a 50 percent LLC membership interest in DB Products Arizona, LLC. The second is a secured promissory note with DB Arizona of $825,000, plus accrued interest.  General Cannabis paid $106,001 for the acquisition of GC Arizona.  Infinity Capital is owned by General Cannabis’ Chairman of the Board, Mr. Michael Feinsod. DB Arizona produces and distributes medical marijuana infused products in Arizona.

General Cannabis Corp. (CANN), closed Wednesday's trading session at $1.85, up 3.06%, on 84,647 volume with 177 trades. The average volume for the last 60 days is 133,756 and the stock's 52-week low/high is $0.68/$5.19.


The QualityStocks
Company Corner


Lexaria Bioscience Corp. (LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP). Today, Lexaria Bioscience Corp. closed trading at $0.309, off by 0.32%, on 21,547 volume with 14 trades. The stock’s average daily volume over the past 60 days is 96,459 and its 52-week low/high is $0.09/$0.699.

Lexaria Bioscience Corp. (LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including cannabinoids. Though boasting a wide range of health benefits, cannabinoids are traditionally poorly absorbed by the body's gastrointestinal tract. To achieve higher effectiveness, consumers usually default to smoking. Lexaria provides a superior administration method by delivering hemp oil ingredients – or through locally licensed partners, cannabis oil ingredients – through a patented process within food products.

The key differentiator between Lexaria's products and others on the market is the company's disruptive technology proven to enhance the absorption of orally ingested cannabinoids while improving the "unusual" taste of cannabinoids and allowing for lower overall dosing with higher efficacy. Lexaria is primarily a B2B enterprise, and is in licensing discussions or has existing agreements with companies in Canada, the largest-market states in the USA, and internationally. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within lipids in popular foods. These brands include ViPova™, Lexaria Energy Foods, and TurboCBD™.

In 2015, Lexaria commissioned an independent, third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company's technological process and lipid formulation both improve intestinal absorption as much as 500%. Additional follow-up studies in human volunteers suggested that Lexaria's processed, lipid-infused tea may be more effective in an actual gastrointestinal system than in an in vitro simulation with results indicating as much as a 1,000% increase in overall absorption.

Lexaria also has an R&D partnership with the Canadian government's National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria's unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D are expected to support accelerating B2B relationships – not just in the cannabis industry, but also to support new B2B business relationships in the fields of vitamins, NSAIDs, and nicotine delivery. All of these sectors expected to offer additional future growth potential.

Aside from testing, a critical component of Lexaria Bioscience's business model is a strong intellectual property portfolio that utilizes the most commonly used food processing techniques. As of 2017, the company's patent portfolio includes 19 patent applications filed and pending in more than 40 countries around the world. The most recent patent applications expand Lexaria's lipophilic food and beverage composition claims to include the processing of cannabinoids, vitamins, NSAIDs and nicotine in many of the world's most commonly used food processing ingredients. Lexaria is expecting additional new patent awards both in the USA and internationally in 2017 and 2018.

Royalties play a vital role in Lexaria's revenue-generating business model. The company out-licenses its technology (royalty) to third party partners, and has several deals signed and/or pending. The company's growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has raised more than $50 million in working capital for the companies he has led over the course of his career. He is supported by a team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets. Disclaimer

Lexaria Bioscience Corp. Blog

Lexaria Bioscience Corp. News:

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) is “One to Watch”

Lexaria Bioscience Corp. is a Technology Disruptor in Edible Cannabinoids

Lexaria Appoints New Acting CFO

CD International Enterprises, Inc. (CDII)

The QualityStocks Daily Newsletter would like to spotlight CD International Enterprises, Inc. (CDII). Today, CD International Enterprises, Inc. closed trading at $0.0028, up 16.67%, on 3,791,647 volume with 74 trades. The stock’s average daily volume over the past 60 days is 3,379,448 and its 52-week low/high is $0.0001/$2.00.

CD International Enterprises, Inc. today announced that the Company has entered into a purchase contract to purchase 10,000 tons of copper concentrate (30% Cu) per month or 120,000 tons over 12 months with a Chile-based company. Per the purchase contract, CD International agrees to purchase 10,000 metric tons of copper concentrate (30% Cu) per month over a period of 12 months. The total shipment over a period of 12 months will be 120,000 metric tons of copper concentrate. The initial 12 months contract of 120,000 metric tons of copper concentrate values approximately US $260 million on basis of the current copper future price on the London Metal Exchange.

CD International Enterprises, Inc. (CDII) is a U.S.-based company operating in two primary business segments: mineral trading and consulting services. Headquartered in Deerfield Beach, Florida, with operations centering on the rapid growth of the Chinese economy, CDII allows prospective investors to participate in the considerable opportunities presented by emerging markets in both the People's Republic of China and the Americas.

CDII Minerals, Inc., a wholly-owned subsidiary of CD International, serves as its commodities trading division. Through CDII Minerals, CDII sources, aggregates and distributes iron ore, manganese ore and scrap metals for clients operating throughout China. The company maintains a strategic position between its North and South American suppliers and its Chinese clients, allowing it to both address a niche market opportunity and facilitate more efficient transactions for its customers.

In addition to its mineral trading services, CDII has found success in offering a comprehensive suite of consulting services related to the unique characteristics of business operations in China. In December 2016, the company announced its entry into a two-year corporate agreement with a China-based subsidiary of Everbright International Construction Engineering Corporation, through which CDII will provide information related to foreign and domestic constructions, project tending offers, government communications and local networks. In January 2017, CDII announced its entry into a similar agreement with Zhangjiajie Shengshi Agricultural Development Company, through which it will provide consulting services related to a number of business developments, including the development of a distribution business centered on cannabidiol extract derived from industrial hemp.

Per the company's website, CDII's greatest strength lies in the quality of its personnel, which includes a culturally diverse group of professionals operating within the United States, as well as in China and emerging markets throughout the Americas. Dr. James Wang has served as CEO and chairman of the CDII board since August 2006. He has also served as CEO and chairman of China Direct Investments since January 2005. Wang brings a wealth of experience in corporate finance in the U.S. capital markets to the CDII management team, and his work in the identification and acquisition of China-based growth companies has played an instrumental role in the execution of CD International's strategic vision for over a decade.

Wang is joined on the CDII management team by Controller Shirley Xu and Vice President of Business Development Katie Zhao. Xu has served as the company's controller since January 2013, assuming a range of responsibilities including internal control, general ledger accounting oversight, and financial reporting for CDII and its subsidiaries. She is also responsible for SEC financial reporting for the company's consulting segment clients.

Katie Zhao has served in her current role with CD International since January 2012. Prior to becoming VP of business development, she served as the company's project manager from 2007 to 2009 and as senior account executive from 2010 to 2011. From these positions, Zhao played a key role in the establishment of CDII's U.S. distribution channels for its Chinese clients, as well as the implementation of a network connecting the company's U.S. and China-based offices. Disclaimer

CD International Enterprises, Inc. Blog

CD International Enterprises, Inc. News:

CD International Enterprises (CDII) Enters a Purchase Contract to Purchase Copper Concentrate of 120,000 Tons Over 12 Months

CD International Enterprises Signs Full Corporate Offer to Purchase 1.2 Million Tons of Metallurgical Grade Bauxite

CD International Enterprises Enters Wholesale Distribution Agreement With Leading Global Supplier of Cannabidiol/Hemp-Derived Products

Singlepoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight Singlepoint, Inc. (SING). Today, Singlepoint, Inc. closed trading at $0.0195, up 4.84%, on 9,531,449 volume with 262 trades. The stock’s average daily volume over the past 60 days is 6,690,846, and its 52-week low/high is $0.0075/$0.142.

NetworkNewsWire Editorial Coverage: The burgeoning legalized marijuana market is increasingly populated with unique contenders, and success in this market requires a high caliber of innovation that drives compounding potential for revenue growth, success and sustainability. SinglePoint, Inc. (SING) (SING Profile), for example, employs a diversified acquisition strategy in tandem with a plan to develop a crypto currency solution for the cannabis industry with First Bitcoin Capital Corp. (BITCF).

Singlepoint, Inc. (SING) has grown from a full-service mobile technology provider to a publicly-traded holding company. Through diversification into horizontal markets, SinglePoint is building its portfolio by acquiring an interest in undervalued subsidiaries, thereby providing a rich, diversified holding base.

SinglePoint's approach is to first research and identify acquisition opportunities in which it can take an active and influential role among existing leadership to provide enhanced strategy and direction. Target companies are undervalued, cash-flow positive, with high potential and verified assets. SinglePoint acquires and takes controlling interest of successful candidate companies.

SinglePoint recently signed a Letter of Intent to acquire an interest in Jacksam Corp., dba Convectium, a profitable California-based provider of equipment, branding, and packaging solutions for the cannabis industry. Convectium has developed the world's first cartridge and vape pen oil filling machine for wholesale distribution to dispensaries. The 710Shark and 710Seal systems can fill and package over 100 cartridges or disposable vape pens in 30 seconds and are sold to dispensaries through its EquipCanna.com brand. The company also operates a consumer brand that includes BlackoutX and HazeSticks and reaches customers in over 52 countries.

Additionally, SinglePoint has raised more than $300,000 and has signed a Letter of Intent to secure an additional $1 million in funding. The move provides management with ample capital to execute its business plan, while avoiding debt repayments that can eat into cash flow and reduce flexibility over time. It's also a rare development for a development-stage company in the cannabis industry.

Guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital, SinglePoint continues to explore high-potential acquisition opportunities to grow and diversify its current holding base. The company also plans to uplist to the OTCQB and become a fully reporting company during the current fiscal year.

The company has engaged Milost Advisors to pursue acquisitions and financing facilities toward funding acquisitions, as well as to provide working capital. Milost Advisors will assist SinglePoint in the acquisition of undervalued companies with annual revenues of at least $50 million, and has already identified potential acquisition targets for the company to consider. Disclaimer

Singlepoint, Inc. Company Blog

Singlepoint, Inc. News:

What it takes to Stand Out from the Crowd in the Legalized Marijuana Space

SinglePoint Signs Deal to Manufacture CBD Hemp Oil Patches -- CFN Media

Premier Biomedical Launches Volume Manufacture of Topical Pain Relief Products Enabling Significant Expansion of Business

ProBility Media Corp. (PBYA)

The QualityStocks Daily Newsletter would like to spotlight ProBility Media Corp. (PBYA). Today, ProBility Media Corp. closed trading at $0.6972, up 39.44%, on 5,530 volume with 5 trades. The stock’s average daily volume over the past 60 days is 3,065, and its 52-week low/high is $0.1205/$1.16.

ProBility Media Corp. (PBYA) based in Houston, TX, is an EdTech Company that is building the first full service training and career advancement brand for the skilled trades. Through both acquisitions and organic growth, ProBility is executing a disruptive strategy of defragmenting the market place of disparate companies servicing fifteen vertical categories in over sixty skilled trades. ProBility has positioned itself as a key industrial training resource for individuals, small- and medium-size businesses as well as enterprise customers offering consistent high-quality training services and materials for education, testing, and career advancement.

Through its Electrical Training Division, the company has become the biggest wholesaler of electrical codes and test preparation materials in the U.S., while its Construction Training Division is one of the largest certification providers in the country, with programs in 22 states, and continuing to grow. The company serves corporate accounts and government buyers, and also offers advisory services for companies of all sizes.

Companies currently under the ProBility Media conglomerate include:

  • Brown Technical Media Corp. – An online web business with multiple micro web sites featuring training materials and codes and standards sought by engineers, construction workers, scientists and other tradesmen in a wide variety of fields.
  • Brown Technical Publications – A proprietary publishing business generating copyrighted training materials for engineers, construction workers, scientists and other tradesman in a wide variety of fields.
  • 1ExamPrep – E-Learning, education and exam preparation for contractors via the cheapest, fastest and most effective exam prep school in the industry instituting our 4-point proven learning system.
  • National Electrical Wholesale Providers – In the business of distributing wholesale industrial, commercial and residential training materials including HVAC, plumbing and electrical.

ProBility's technology platform features virtual reality training for the crane business to be expanded into other industries, online subscription services for enterprise level companies, and recurring revenue streams. In addition, the company is already beginning to explore international expansion options, supported by the fact that other countries have adopted U.S. based codes, and have used U.S. training services.

The company's acquisition strategy targets operations that service engineering firms, electrical contractors, fabricators, plumbing contractors, pipe fitters, riggers, QC firms, and additional vocational industries. Disclaimer

ProBility Media Corp. Company Blog

ProBility Media Corp. News:

ProBility Media Corp. Selects PCG Advisory Group for Investor Relations and Strategic Communications

ProBility Media Corp. Closes the Acquisition of W Marketing

ProBility Media Corp. Reports Fourth Consecutive Quarter of Revenue Growth

Players Network, Inc. (PNTV)

The QualityStocks Daily Newsletter would like to spotlight Players Network, Inc. (PNTV). Today, Players Network, Inc. closed trading at $0.212, up 9.84%, on 6,899,899 volume with 845 trades. The stock’s average daily volume over the past 60 days is 3,848,582, and its 52-week low/high is $0.0023/$0.2085.

Players Network, Inc. (PNTV) is a diversified holding company operating in marijuana and media. PNTV owns 86% of Green Leaf Farms Holdings, LLC (Green Leaf Farms) which has Nevada state-issued cultivation and production license(s). The cultivation license enables Green Leaf Farms to grow marijuana and the production license enables them to create extracts which are used for cartridges, oils and edibles. WeedTV.com is a wholly owned subsidiary which is developing the ultimate resource for the marijuana lifestyle. PNTV has been a fully reporting, publicly traded company since 1998.

Green Leaf Farms Holdings, LLC (Green Leaf)

Green Leaf produces medical and recreational cannabis products. Revenues are generated by selling their cannabis products to licensed dispensaries throughout Nevada.

Their mission is to produce the highest quality and safest pharmaceutical-grade cannabis to all levels of consumers. They utilize the most efficient cultivation methods in order to lower expenses for consumers and to maximize returns for investors.

They are a privately held company with a unique business model as they are one of only a few companies who have been granted 2 (two) Medical Marijuana Establishment (MME) licenses in Nevada; Cultivation and Production.

Their Cultivation License enables them to grow cannabis which will produce flower. Their Production License enables them to process flower (cannabis) and cannabis byproducts into extremely pure concentrates, extracts, and oils which are used in medicine, cartridges and edibles. Green Leaf has both acquired and developed proprietary cannabis strains and will continue to be committed to cannabis research and development.

Green Leaf is located in North Las Vegas, Nevada on 2.3 acres in a state-of-the-art 26,000 sq. ft. facility. They have a seasoned team of professional growers and operators to manage the facility with proven best practices to ensure they have the highest quality products available.


WeedTV.Com is a niche social network and lifestyle channel destination for the marijuana industry. They are developing the "go-to" source for information, entertainment, products and services for people who relate to the marijuana lifestyle and an active social community. WeedTV.com features daily stories sourced by WeedTV.com correspondents and contributors from around the world.

Programming includes, political news, business news on the industry, financial analysis from industry experts, growing tips, cooking tips, the "Weed101" section, medical applications/issues, lifestyle features, and entertainment specials.

WeedTV.com's first original series is titled "High Stakes." High Stakes was developed by Michael Berk, the company's Chief Creative Officer and creator of one of the most popular cable series of all time, Baywatch. High Stakes is docu-series that follows the team at Green Leaf Farms as they build their facility and launch their marijuana business.

By leveraging media, WeedTV.com builds long-term brand equity and connects consumers to businesses. This is accomplished through fresh and relevant content such as professionally produced branded television segments, user-generated videos, blogs, editorials, tweets (twitter), photos, special offers, events and custom-designed contests to engage both consumers and businesses with their brands and services.

Marijuana and Media Strategy

While developing WeedTV.com, the PNTV team realized they could implement a vertical strategy to utilize their media platform (WeedTV.com) to drive business and awareness to their cannabis products (Green Leaf Farms). Through the audience and reach of WeedTV.com, they will build brand value and cross market their own marijuana products, as well as generate revenues by marketing other companies' products and services. Disclaimer

Players Network, Inc. Company Blog

Players Network, Inc. News:

Player's Network's Weed TV to Live Broadcast First Recreational Marijuana Transaction at Pisos Dispensary in Las Vegas

Player's Network, Inc. Appoints Geoffrey Lawrence, Nevada Assistant State Controller, as Chief Financial Officer, Chief Compliance Officer

Player's Network, Inc. CEO Featured on MoneyTV with Donald Baillargeon, 6/2


Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters



(ATCV) +918.52%


Damn Good Penny Picks
(BMXI) +41.87%


(PBYA) +39.44%

By The Numbers Charts

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors


The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.


About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251